Systolic and diastolic short-term blood pressure variability and its determinants in patients with controlled and uncontrolled hypertension: A retrospective cohort study

Blood Pressure

Volumn 24, Issue 2, 2015, Pages 124-129

  Pengo, Martino F ^a   Rossitto, Giacomo ^a   Bisogni, Valeria ^a   Piazza, Daniele ^a   Frigo, Anna Chiara ^a   Seccia, Teresa Maria ^a   Maiolino, Giuseppe ^a   Rossi, Gian Paolo ^a   Pessina, Achille C ^a   Calò, Lorenzo A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Absolute blood pressure; Ambulatory blood pressure monitoring; Blood pressure variability; Resistant hypertension; Sympathetic system

Indexed keywords

ANTIHYPERTENSIVE AGENT; CAPTOPRIL;

ADULT; AGE; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; COHORT ANALYSIS; CONTROLLED STUDY; DAY LENGTH; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NIGHT; NORMAL VALUE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RESISTANT HYPERTENSION; RETROSPECTIVE STUDY; SEX RATIO; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; HYPERTENSION; PATHOPHYSIOLOGY; PROCEDURES;

BLOOD PRESSURE MONITORING, AMBULATORY; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84924482716     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2014.992187     Document Type: Article

References (26)

1. Pessina AC, Palatini P, Sperti G, Cordone L, Libardoni M, Mos L, et al. Evaluation of hypertension and related target organ damage by average day-time blood pressure. Clin Exp Hypertens 1985; 7: 267-278.
2. Mena L, Pintos S, Queipo NV, Aizpúrua JA, Maestre G, Sulbarán T. A reliable index for the prognostic significance of blood pressure variability. J Hypertens. 2005; 23: 505-511.
3. Hansen TW, Thijs L, Li Y, Boggia J, Kikuya M, Björklund-Bodegård K, et al. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension. 2010; 55: 1049-1057.
4. Parati G, Ochoa JE, Bilo G. Blood pressure variability, cardiovascular risk, and risk for renal disease progression. Curr Hypertens Rep. 2012; 14: 421-431.
5. Mancia G, Parati G, Pomidossi G, Casadei R, Di Rienzo M, Zanchetti A. Arterial baroreflexes and blood pressure and heart rate variabilities in humans. Hypertension. 1986; 8: 147-153.
6. Bilo G, Giglio A, Styczkiewicz K, Caldara G, Maronati A, Kawecka-Jaszcz K, et al. A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J Hypertens. 2007; 25: 2058-2066.
7. Manios E, Tsagalis G, Tsivgoulis G, Barlas G, Koroboki E, Michas F, et al. Time rate of blood pressure variation is associated with impaired renal function in hypertensive patients. J Hypertens. 2009; 27: 2244-2248.
8. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010; 9: 469-480.
9. Zhang Y, Agnoletti D, Safar ME, Blacher J. Effect of antihy-pertensive agents on blood pressure variability: The Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CEL-LENT) study. Hypertension. 2011; 58: 155-160.
10. Mancia G, Parati G, Bilo G, Maronati A, Omboni S, Baurecht H, et al. Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: Data from the European Lacidipine Study on Atherosclerosis. J Hypertens. 2007; 25: 1087-1094.
11. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion J-M, Mancia G, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003; 2: 821-848.
12. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: Diagnosis, evaluation, and treatment a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008; 51: 1403-1419.
13. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, et al. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res. 1983; 53: 96-104.
14. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999; 282: 539-546.
15. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: Follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005; 111: 1777-783.
16. Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: A prospective study. Hypertension. 1998; 31: 712-718.
17. Fagard RH, Van Den Broeke C, De Cort P. Prognostic sig-nificance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens. 2005; 19: 801-807.
18. Verdecchia P, Angeli F, Gattobigio R, Rapicetta C, Reboldi G. Impact of blood pressure variability on cardiac and cerebrov-ascular complications in hypertension. Am J Hypertens. 2007; 20: 154-161.
19. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: A cohort study. Lancet. 2007; 370: 1219-1229.
20. Conway J, Boon N, Davies C, Jones JV, Sleight P. Neural and humoral mechanisms involved in blood pressure variability. J Hypertens. 1984; 2: 203-208.
21. Izzo JL Jr, Yedlapati SH, Faheem SM, Younus U, Osmond PJ. Differences in mean and variability of heart rate and ambulatory rate-pressure product when valsartan or carvedilol is added to lisinopril. J Am Soc Hypertens. 2012; 6: 399-404.
22. Bombelli M, Toso E, Peronio M, Fodri D, Volpe M, Brambilla G, et al. The Pamela study: Main findings and perspectives. Curr Hypertens Rep. 2013; 15: 238-243.
23. Pessina AC. Home blood pressure monitoring in the elderly. Cardiology in the Elderly. 1993; 1: 494-499.
24. Muxfeldt ES, Bloch KV, Nogueira A da R, Salles GF. True resistant hypertension: Is it possible to be recognized in the office? Am J Hypertens. 2005; 18(12 Pt 1): 1534-1540.
25. Syrseloudis D, Andrikou I, Andrikou E, Dimitriadis K, Stefanadis C. Ambulatory blood pressure monitoring in resistant hypertension. Int J Hypertens. 2011; 2011: 285612.
26. Di Rienzo M, Grassi G, Pedotti A, Mancia G. Continuous vs intermittent blood pressure measurements in estimating 24-hour average blood pressure. Hypertension. 1983; 5: 264-269.